Page 2,084«..1020..2,0832,0842,0852,086..2,0902,100..»

Category Archives: Transhuman News

Non-Chromosomal DNA Drives Tumor Evolution | The Scientist … – The Scientist

Posted: February 9, 2017 at 5:48 am


The Scientist
Non-Chromosomal DNA Drives Tumor Evolution | The Scientist ...
The Scientist
Researchers discover that short pieces of DNA harboring oncogenes are relatively widespread in cancer.

and more »

Go here to see the original:
Non-Chromosomal DNA Drives Tumor Evolution | The Scientist ... - The Scientist

Posted in DNA | Comments Off on Non-Chromosomal DNA Drives Tumor Evolution | The Scientist … – The Scientist

Quinoa genome unveiled in search for hardy crop to feed world … – The Guardian

Posted: at 5:47 am

Quinoa is harvested in the highlands in Puno region, south-eastern Peru. The crop could help improve global food security. Photograph: ICT/Tomas Munita

The near-complete genome of quinoa was unveiled on Wednesday by scientists who say the grain cultivated centuries ago by Incas in the Andes could help feed a hungry world.

Quinoa is incredibly resilient, and can grow in poor or salty soils, said Mark Tester, a professor at King Abdullah University of Science and Technology in Saudi Arabia and leader of the consortium of scholars that decoded the plants genome.

It could provide a healthy, nutritious food source for the world using land and water that currently cannot be used.

Other major crop plants have been bred for centuries or, more recently, genetically modified to combine optimal traits to boost yield and bolster resistance to pests and climate change. Now, scientists can delve into the quinoa genome as well.

Quinoa has great potential to enhance global food security, Tester said.

The grain thrives at any altitude up to 4,000 metres (13,000 feet) above sea level, in conditions that would leave most food plants struggling. Some strains grow well at temperatures up to 38 degrees.

Best known outside its native region as a health food, quinoa is gluten-free and contains essential amino acids, fibre, vitamins and minerals.

It also scores lower than other crops on the glycaemic index, a measure of how quickly foods raise blood sugar levels a major concern for those with diabetes.

Yet global consumption remains incidental compared with wheat, rice, barley or corn less than 100,000 tonnes a year compared with hundreds of millions of tonnes for each of the other major grains and cereals.

One problem with quinoa is that the plant naturally produces bitter-tasting seeds, Tester explained. The bitterness a natural defence against birds and other pests comes from chemical compounds called saponins. The process for removing these chemicals is labour-intensive and costly, and requires ample use of water.

Another constraint is that quinoa plants tends to have small seed heads and long stalks that can collapse in strong wind or heavy rain.

Despite its agronomic potential, quinoa is still an underutilised crop, with relatively few active breeding programmes, Tester and three dozen colleagues wrote in the journal Nature.

First grown by humans thousands of years ago in the high plateau around Lake Titicaca in the Andes, quinoa is still barely domesticated, the researchers said.

Testers team has already pinpointed genes, including one that controls the production of saponins, that could be altered through breeding or gene editing to enhance quality and yields.

With this new knowledge of quinoa DNA, we can quickly and easily select plants that do not produce bitter substances in the breeding process, said co-author Robert van Loo, a scientist at Wageningen University and Research Centre in the Netherlands. South American varieties could probably be made sweeter with a single gene change, he added.

Most quinoa is grown in three Andean countries: Peru, Ecuador and Bolivia.

The United States and Canada account for nearly 70% of exports, followed by France, the Netherlands and Germany. The price of quinoa has nearly tripled in recent years due to increased demand.

If printed, the sequence of letters corresponding to the quinoa genome comprised of 1.3bn molecular building blocks would take up 500,000 pages.

Original post:
Quinoa genome unveiled in search for hardy crop to feed world ... - The Guardian

Posted in Genome | Comments Off on Quinoa genome unveiled in search for hardy crop to feed world … – The Guardian

Quinoa genome accelerates solutions for food security (Update) – Phys.Org

Posted: at 5:47 am

February 8, 2017 The sequencing of the first high-quality quinoa genome by a KAUST-led research team could one day help transform our ability to feed the world's growing population. Credit: 2017 KAUST Linda Polik

An international team of scientists, including quinoa breeding experts from Wageningen University & Research, published the complete DNA sequence of quinoa the food crop that is conquering the world from South America in Nature magazine on 8 February 2017. Quinoa is rich in essential amino acids and nutritional fibres and does not contain gluten. The crop is important to farmers as it provides a reasonable yield even on poor soils. The new knowledge about quinoa DNA is already being used by breeders who are developing quinoa varieties which grow well in saline soil and still meet the taste requirements of consumers.

The scientists determined the sequence of the DNA-building blocks of the entire quinoa genome. The total length of the DNA, the 'genome', consists over a little over 1.3 billion DNA building blocks (the nucleotides A, C, G or T), divided over 18 chromosomes. Printed on paper this would add up to over 500,000 pages of text.

To map the DNA building blocks, the scientists used a smart combination of various DNA sequencing techniques. While this enabled them to put together ever-larger DNA segments in the computer from the huge amount of DNA information available, it did not lead to the 18 segments which represent the 18 chromosomes. The scientists therefore applied genetic maps that were made by crossbreeding plants to determine how molecular markers were inherited by the offspring. This allowed them to place most of the DNA on 18 large DNA-strains, representing the quinoa chromosomes.

According to Robert van Loo, expert in quinoa breeding at Wageningen University & Research, it was this combination that allowed the scientists to clearly map the DNA. "We were able to determine the location on the chromosome of no less than 85% of the DNA-sequence. This is a major benefit for plant breeders."

Van Loo and his colleagues will be using the new knowledge in various ways, including the development of quinoa varieties which meet the demands of both consumers and farmers. Van Loo: "For example, we discovered mutations which ensure that certain quinoa varieties cannot produce bitter tasting saponins. These 'sweet' varieties do not need to be polished to remove the bitter substances, saving some 15 to 20 per cent. With the new knowledge of quinoa DNA, we can quickly and easily select plants that do not produce bitter substances in the breeding process."

In the future, scientists can probably ensure that specific varieties such as those that are well adapted to the cultivation conditions in a specific region do not produce bitter substances.

"Gene directed mutation breeding could be a good approach in this regard, with varieties that have already proven their value regionally being the starting point," says Van Loo. "The varieties which are currently being grown in South America can probably be made sweet with one specific mutation."

The research was led by the King Abdullah University of Science and Technology in Saudi Arabia, a region with difficult growth conditions for plants and with many poor or even saline soils. Wageningen University & Research provided DNA sequencing experts and breeding scientists to contribute to the research. It was this Wageningen team that made the genetic maps on which the gene which regulates the production of saponin (bitter substance) was found.

Ancient civilisations in the Andes already used quinoa as an important food crop. It faded into the background with the arrival of the Spanish, however, which is why quinoa was never truly 'domesticated' despite being such a good and healthy food crop.

One of the properties that makes quinoa less attractive is the presence of bitter substances on the outside of the seeds. Known as saponins, these substances can be removed from the seeds although the process costs time, money and water. Wageningen University & Research has already developed four varieties without bitter substances since the 1990s.

Quinoa is part of a plant family known for its growing power in extreme conditions, such as in poor soils, at high altitudes and even in saline soils. There are already various quinoa varieties which produce food in places where other food crops, such as wheat and rice, have very poor yields. As a result, quinoa is seen as a crop that can help produce extra food with fewer inputs of water and fertiliser. The new knowledge of the DNA will accelerate the development of extra sustainable quinoa varieties which also meet other demands from farmers and consumers alike.

Explore further: Bitter chemical coating leads to quinoa success

More information: The genome of Chenopodium quinoa, Nature, nature.com/articles/doi:10.1038/nature21370

Journal reference: Nature

Provided by: Wageningen University

The challenge posed by removing a chemical compound from their 'superfood' crop to create a market for WA quinoa led three innovative farmers to build Australia's largest quinoa processing plant in the state's south-west.

To the south of Nash Huber's farm fields are the Olympic Mountains, peaking at nearly 8,000 feet. Due north is the end of a channel of Pacific Ocean waters that separate the United States from Canada.

(HealthDay)The grain quinoa seems safe for people with celiac disease, a new British study suggests.

Consumers can't get enough of the superfood quinoa, healthy grains which originate from and thrive in South America. Wageningen UR has developed three varieties that also do well elsewhere in the world.

Algae is evolving as the next new alternative protein source consumers are anxious to bite into as an ingredient in crackers, snack bars, cereals and breads, according to a July 12th presentation at IFT15: Where Science Feeds ...

The capacity to feed the world's growing population will be greatly improved by developing crops able to tolerate higher soil salinity and salt water irrigation. Researchers at King Abdullah University of Science and Technology ...

An international team of scientists, including quinoa breeding experts from Wageningen University & Research, published the complete DNA sequence of quinoa the food crop that is conquering the world from South America ...

Scientists studying oysters along the Atlantic Coast have discovered a critical clue to understanding why more seafood lovers are getting sick from eating shellfish.

The flashlight fish uses bioluminescent light to detect and feed on its planktonic prey, according to a study published February 8, 2017 in the open-access journal PLOS ONE by Jens Hellinger from Ruhr-University, Bochum, ...

An investigation into the evolution of human walking by looking at how chimpanzees walk on two legs is the subject of a new research paper published in the March 2017 issue of Journal of Human Evolution.

A compound extracted from a deep-water marine sponge collected near the Bahamas is showing potent antibacterial activity against the drug resistant bacteria methicillin-resistant Staphylococcus aureus (MRSA). Also called ...

A group of insects that mimic each other in an effective golden sheen to fight predators has been discovered as the largest in Australia, a collaboration between Masaryk University and Macquarie University researchers has ...

Adjust slider to filter visible comments by rank

Display comments: newest first

When Chimeras of Animals can be made, why not mix it up with various food crops?

GM plants owned by big corp is the furthest thing from food security.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Excerpt from:
Quinoa genome accelerates solutions for food security (Update) - Phys.Org

Posted in Genome | Comments Off on Quinoa genome accelerates solutions for food security (Update) – Phys.Org

‘Dark genome’ could yield answers to complex genetic diseases – Genetic Literacy Project

Posted: at 5:47 am

The mysterious majority as much as 98 percent of our DNA do not code for proteins. Much of this dark matter genome is thought to be nonfunctional evolutionary leftoversHowever, hidden among this noncoding DNA are many crucial regulatory elements that control the activity of thousands of genes.

[In an] effort to fully map and annotatethe human genome, including this silent majority, the National Institutes of Health (NIH)announced new grant funding for a nationwide project to set up five characterization centersto study how these regulatory elements influence gene expression andcell behavior.

By cataloging the functions of thousands of regulatory sequences, [researchers] hope to develop rules about how to predict and interpret other sequences functions. This would not only help illuminate the rest of the dark matter genome, it could also reveal new treatment targets for complex genetic diseases.

A lot of human diseases have been found to be associated with regulatory sequences, said [Nadav Ahituv, a professor of bioengineering at UC San Francisco]. For example, in genome-wide association studies for common diseases, such as diabetes, cancer and autism, 90 percent of the disease-associated DNA variants are in the noncoding DNA. So its not a gene thats changed, but what regulates it.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post:The mysterious 98%: Scientists look to shine light on the dark genome

More here:
'Dark genome' could yield answers to complex genetic diseases - Genetic Literacy Project

Posted in Genome | Comments Off on ‘Dark genome’ could yield answers to complex genetic diseases – Genetic Literacy Project

Alexandra Wolfe’s ‘Valley of the Gods’ follows Thiel Fellows on their … – Silicon Valley Business Journal

Posted: at 5:47 am

Alexandra Wolfe's 'Valley of the Gods' follows Thiel Fellows on their ...
Silicon Valley Business Journal
Journalist Alexandra Wolfe tells the tales of the strivers and strangeness behind Silicon Valley startup culture in her new nonfiction book Valley of the Gods..

and more »

View post:
Alexandra Wolfe's 'Valley of the Gods' follows Thiel Fellows on their ... - Silicon Valley Business Journal

Posted in Human Longevity | Comments Off on Alexandra Wolfe’s ‘Valley of the Gods’ follows Thiel Fellows on their … – Silicon Valley Business Journal

Hacking longevity – Telangana Today

Posted: at 5:47 am

With software at the heart of every industry today, an interesting question arises: Can the human body be controlled by code?

The onset of the new renaissance means, most new age businesses can now be controlled by coders huddled in a lab.

The surge prices on uber are controlled by coders and so are the number of cars available in a location. When Tesla realises theres an error with the charger plug that comes with the car, it simply delivers an Over the air update in real time, instead of having to recall the cars. Hackers today are known to be sitting in an aeroplane, plugging into the aircraft LAN and can potentially take control. With software at the heart of every industry today, an interesting question arises: Can the human body be controlled by code ?

Turns out: Of course!

Gene editing techniques have been around for thousands of years. In the ancient past this was achieved by selective breeding. Thats how you end up with exotic dog breeds like the Dalmatian. Over the last few decades, more aggressive techniques like creating artificial mutations by subjecting organisms to radiation, and clogging the organism with new genetic material with the hope that some of it will stick have been invented. Most produce that one sees in the supermarket today is a product of such experimentation, More popularly known as GMOs. These techniques are cumbersome, error prone and its often difficult to predict results accurately.

Things have changed dramatically in the last few years with the discovery of a new gene editing technique called CRISPR CAS 9. CRISPR CAS 9 techniques allow a regular biologist in the lab to have access to sophisticated gene editing equipment and materials for less than 2000 dollars.

So what is gene editing really? Each human cell consists of 23 pairs of chromosomes, inherited in equal numbers both from the mother and father. Each chromosome is made up of billions of molecules of DNA. DNA can be categorized into thousands of units called genes. Each gene has enough information to express one protein. Sometimes errors can creep into the genetic code. Instead of having the letter T, the gene can have G at a crucial location. DNA is pretty much the operating manual for how a cell should go about its business, and you have a copy of it with each and every cell. Therefore any such error can create an effect across the body.

Where CRISPR comes in here, is that using these tools clinical biologists are able to remove an incorrect gene and replace that with a gene that will be more beneficial.

For example, if you have an individual suffering from sickle-cell anemia, there is a possibility in a few years that the patient is injected with a virus carrying CRISPR CAS 9 protein can traverse the body and replace all faulty genetic material with new material that fixes the problem. There is also the possibility that patients suffering from cancer can have CRISPR edited antibodies that fight all the bad cancer causing cells and kill them. CRISPR offers this wonderful opportunity to develop highly personalized proteins to deal with patients suffering from severe genetic challenge and increase their longevity.

CRISPR is an approach that bacteria have been using for millions of years to protect themselves from regular invasions by harmful viruses. With the same approach humans today are trying to use in a variety of applications ranging from creating super foods to eliminating genetic illnesses, improving human longevity, personalizing medicine and bringing down the quality of healthcare.

Having said that, last year U.S. director of national intelligence, James Clapper, ominously declared that genome editing was a potential weapon of mass destruction. With the democratization of access to CRISPR technology, now every qualified individual can potentially do experiments editing the gene pool. For example, Verily, an Alphabet company, is looking to create genetically altered male mosquitos that on mating with the female anopheles mosquito can create a generation of sterile mosquitoes. This will make sure that in a few years, these types of mosquitos will not exist anymore. While this is great news for people, it may not be equally beneficial for the ecosystem. There are many animals and birds that might be part of the mosquito ecosystem, and depend on it for their survival. Thus secondary, tertiary and changes beyond that can create a world that we no longer might recognize.

While its a great opportunity for countries like India to do research in a highly competitive space like this, we also need to be cognizant of the potential harm, and therefore there is a strong case for legislation globally.

The author is CEO of [x]cubeLABS

More here:
Hacking longevity - Telangana Today

Posted in Human Longevity | Comments Off on Hacking longevity – Telangana Today

Atopic eczema is like an ‘asthma of the skin’ – MSR News Online

Posted: at 5:47 am

Good news: New medicines coming out will greatly help in the treatment of atopic eczema Child with atopic eczema before (l) and after treatment

Eczema and dermatitis are both terms with the same meaning: inflammation, redness, and itching of the skin. Atopic eczema (a.k.a. atopic dermatitis) is a skin disease. The first sign of eczema tends to be patches of dry or red, itchy skin. Atopic eczema is controlled by a combination of genetic and environmental factors.

Unfortunately, because dermatitis can be so itchy, aggressive scratching can injure the skin and worsen the condition. Sometimes the itch can precede the rash. Some doctors say atopic eczema is the itch that rashes.

Atopic eczema usually begins very early in life as a condition affecting infants or young children, but it can occur at any age. It is most common in infants and young children, and most people who get eczema will have it before they turn five years old. It is rare for eczema to appear for the first time in adults.

Eczema can be more common and problematic in persons of color. In fact, 25 percent of all children of color (and large percentages of other children as well) can be affected by atopic eczema.

Eczema tends to come and go, often without warning. A treatment plan that includes skin care can reduce flare-ups and ease much of the discomfort.

The good news is that there are excellent new treatments for atopic eczema available now and coming out this summer. I will discuss those shortly.

What causes eczema?

Atopic eczema is a genetic condition. It is often seen in patients whose family members have it or other related conditions such as asthma, hay fever or allergic rhinitis. Some patients may have atopic eczema alone or with several or all of these other conditions.

There is emerging evidence that patients with atopic eczema may have a mild disability to repair their skin barrier. Also, excessive bacteria on the skin with bacterial enzymes (proteases) can make eczema worse. These are two important targets in controlling the disease.

Atopic eczema is not contagious. Dry skin, dry weather, perspiration and illness are several things that can cause atopic eczema to get worse.

How can I tell if my child has eczema?

Atopic eczema presents as red, flakey, itchy patches. In children, it commonly appears on the folds of the elbows and knees and on the scalp, forehead and cheeks, but it can be present anywhere. Atopic eczema itches so much that infants commonly rub their cheeks on bed linens or even carpeting for relief.

In extreme cases, a yellow fluid may even weep from the involved areas. Scratching over extended periods of time will cause the skin to become tough and thicken up. This is a common finding in patients with longstanding eczema that has not been completely controlled.

If you think that your child has atopic eczema, visit a board-certified dermatologist to make sure the diagnosis is correct. A dermatologist can often diagnose eczema by examining the patients skin, as well as by asking historically significant questions about a family history of similar skin rashes or asthma or hay fever.

How long will my child have eczema?

In most children, atopic eczema may get better over time, but their skin will always be more sensitive than those without atopic eczema, even as adults.

How is eczema treated?

A dermatologist will create a specific treatment for the patient with atopic eczema. Most treatment plans consist of:

There is no one treatment for atopic eczema. It is important to follow the treatment plan designed by your dermatologist, and the success in adequately managing atopic eczema depends on carefully following the treatment plan. Dermatologists will develop plans that are both safe and effective for long-term use.

In February of 2017, the FDA has approved a new ointment called Crisaborole (Eucrisa) for the treatment of atopic dermatitis. It is an ointment that is applied twice daily to the affected areas.Many patients are seeing remarkable improvements in just one or two weeks.

Over the past 10 years, there has been an explosion of medicines called biologic treatments for psoriasis. A promising new medication from this class is called Dupilumab. This medicine blocks a special protein receptor (interleukin-4) that controls regulatory proteins (interleukin-4 and interleukin-13) that control how certain white blood cells (type 2 helper T-cells)create inflammation in the skin, the hallmark of atopic eczema. This medicine, and others like it, may be available as soon as this summer.

What will the treatment plan include?

Why see a dermatologist?

When a child has atopic eczema, it is a condition that affects the entire family. It takes time away from other siblings and caregivers and can affect performance in school.

As a dermatologist, I like to tell parents atopic eczema is like having asthma of the skin. Just like asthma, it can wax and wane and have certain triggers. Just like asthma, it is a lifelong condition that needs attention but over time may improve.

With so much information out there, much of it misleading or downright inaccurate, it can be challenging for a parent to know exactly what to do. Dermatologists specialize in treating skin conditions and can help parents make the best-informed decisions for their children.

A dermatologist can develop a specific treatment plan for the atopic eczema patient. With new medicines being approved and released, in combination with the other classic treatments listed above, we will be able to treat atopic eczema better than ever before.

Research has shown that parents who develop a good relationship with their dermatologist and follow a designed treatment plan will have the most success in treating their childs atopic eczema over time.

Charles E. Crutchfield III, MD is a board certified dermatologist and Clinical Professor of Dermatology at the University of Minnesota Medical School.He also has a private practice in Eagan, MN.He received his M.D. and Masters Degree in Molecular Biology and Genomics from the Mayo Clinic. He has been selected as one of the top 10 dermatologists in the United States byBlack Enterprise magazine.Dr. Crutchfield was recognized by Minnesota Medicine as one of the 100 Most Influential Healthcare Leaders in Minnesota. He is the team dermatologist for the Minnesota Twins, Vikings, Timberwolves, Wild and Lynx. Dr. Crutchfield is an active member of both the American and National Medical Associations.

Originally posted here:
Atopic eczema is like an 'asthma of the skin' - MSR News Online

Posted in Eczema | Comments Off on Atopic eczema is like an ‘asthma of the skin’ – MSR News Online

Bionona sticks to online sales in launch of eczema treatment – The National Business Review

Posted: at 5:46 am

Bionona has launched its Atopis eczema cream treatment and will stick to online strategy as it chases "a couple of million" in sales in the first year.

The cream is the brainchild of chief executive Iona Weir, the biochemist who oversaw the development of the Phloe laxative and has taken four to five years to develop in her garage.

The research behind the cream came from her Marsden Fund-backed work on programmed cell death in plants known as apoptosis, and through that time attracted Callaghan Innovation support for its second clinical trial in New Zealand during 2015.

Ms Weir wants Atopis to be the number one eczema product in New Zealand and is also targeting sales in the US in a state-by-state roll-out, starting with Colorado.

"In the states, one in 10 people has eczema, so even if we get 1% of that market, then that's an incredible sized market," she said.

When asked what kind of sales volume target she wants to hit in the first 12 months, Ms Weir says she is aiming for "at least a couple of million".

When Vital Foods launched Phloe in 2007, Ms Weir says it sold out in the first morning and was targeting three million units in the first year.

The company chose to avoid wholesalers and distributors and stick to online sales after her experience with Phloe, which generated half of its sales through online channels.

"We discovered online seemed a much better option," she said. "Why would we lose all that money to wholesalers and distributors if we had a proper online marketing campaign?"

Bionona attracted the backing of former NPT executive chairman Paul Dallimore who used the cream on his own grandchildren and was so impressed that he put money into the first clinical testing in the US three years ago.

The company's New Zealand manufacturing will be done in an Onehunga factory, while Douglas Pharmaceuticals will cover its over the counter grade creams in the US.

Ms Weir says the company has the ability to scale up quickly, with Mr Dallimore "and some of his mates" putting money into the business, and expects to have about 18 months lead-time before "people try to copy us."

She shied away from raising money from the market after a previous experience with venture capitalists put her off, and decided "this time I'm going to take a slower path and do it all myself before bringing the money in."

"It's taken me three times as long, but it's been much more worthwhile," she says.

(BusinessDesk receives funding to help cover the commercialisation of innovation from Callaghan Innovation.)

(BusinessDesk)

Go here to see the original:
Bionona sticks to online sales in launch of eczema treatment - The National Business Review

Posted in Eczema | Comments Off on Bionona sticks to online sales in launch of eczema treatment – The National Business Review

Treatment has no sufficient effect in one of five psoriasis patients – Science Daily

Posted: at 5:46 am

Treatment has no sufficient effect in one of five psoriasis patients
Science Daily
A substantial part of people, one in five, undergoing systemic treatment for psoriasis (i.e. pills taken orally, injections or infusions) still have considerable problems with their disease. This is according to a study with 2,646 Swedish psoriasis ...

More:
Treatment has no sufficient effect in one of five psoriasis patients - Science Daily

Posted in Psoriasis | Comments Off on Treatment has no sufficient effect in one of five psoriasis patients – Science Daily

China Turns to Precision Medicine in Fight Against Cancer … – Bloomberg

Posted: at 5:45 am


Bloomberg
China Turns to Precision Medicine in Fight Against Cancer ...
Bloomberg
When Nisa Leung was pregnant with her first child in 2012, her doctor in Hong Kong offered her a choice. She could take a prenatal test that would require ...

and more »

Read more:
China Turns to Precision Medicine in Fight Against Cancer ... - Bloomberg

Posted in Gene Medicine | Comments Off on China Turns to Precision Medicine in Fight Against Cancer … – Bloomberg

Page 2,084«..1020..2,0832,0842,0852,086..2,0902,100..»